Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Return on Assets (2016 - 2025)

Historic Return on Assets for Heron Therapeutics (HRTX) over the last 13 years, with Q3 2025 value amounting to 0.01%.

  • Heron Therapeutics' Return on Assets rose 1200.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.06% for FY2024, which is 4100.0% up from last year.
  • Per Heron Therapeutics' latest filing, its Return on Assets stood at 0.01% for Q3 2025, which was up 1200.0% from 0.01% recorded in Q2 2025.
  • Over the past 5 years, Heron Therapeutics' Return on Assets peaked at 0.01% during Q3 2025, and registered a low of 0.84% during Q2 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.6% (2021), whereas its average is 0.46%.
  • As far as peak fluctuations go, Heron Therapeutics' Return on Assets crashed by -2800bps in 2021, and later soared by 4400bps in 2024.
  • Heron Therapeutics' Return on Assets (Quarter) stood at 0.66% in 2021, then decreased by -1bps to 0.67% in 2022, then grew by 27bps to 0.49% in 2023, then skyrocketed by 90bps to 0.05% in 2024, then soared by 113bps to 0.01% in 2025.
  • Its Return on Assets stands at 0.01% for Q3 2025, versus 0.01% for Q2 2025 and 0.02% for Q1 2025.